O'Connor Donal
Insider CIK 1625377 · TBPH Director · PRGO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 28,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 74,204 | — | $0 | 6,009 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 28,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 6,000 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 74,204 | — | — | 6,009 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 13,398 | — | $0 | 13,398 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2026-06-12 | 2026-06-16 | 6,009 | — | $0 | 80,213 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2026-05-14 | 2026-05-15 | 7,305 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2026-05-14 | 2026-05-15 | 7,305 | $10.84 | $79.2K | 37,942 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2026-05-14 | 2026-05-15 | 3,507 | $10.84 | $38.0K | 34,435 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2026-05-13 | 2026-05-15 | 16,681 | — | $0 | 16,681 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2025-05-19 | 2025-05-21 | 24,258 | — | $0 | 24,258 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-05-19 | 2025-05-21 | 10,649 | — | $0 | 74,204 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2025-05-14 | 2025-05-16 | 9,904 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2025-05-14 | 2025-05-16 | 7,305 | — | $0 | 7,305 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2025-05-14 | 2025-05-16 | 9,904 | $26.01 | $257.6K | 35,391 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2025-05-14 | 2025-05-16 | 4,754 | $26.01 | $123.7K | 30,637 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2024-05-15 | 2024-05-16 | 8,764 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2024-05-15 | 2024-05-16 | 4,207 | $30.22 | $127.1K | 25,487 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2024-05-15 | 2024-05-16 | 8,764 | $30.22 | $264.8K | 29,694 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2024-05-14 | 2024-05-16 | 9,904 | — | $0 | 9,904 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 23,576 | — | $0 | 23,576 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2024-05-08 | 2024-05-10 | 10,537 | — | $0 | 63,555 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2023-05-17 | 2023-05-19 | 7,778 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2023-05-17 | 2023-05-19 | 7,778 | $32.86 | $255.6K | 24,664 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2023-05-17 | 2023-05-19 | 3,734 | $32.86 | $122.7K | 20,930 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2023-05-15 | 2023-05-17 | 8,764 | — | $0 | 8,764 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-05-02 | 2023-05-04 | 22,044 | — | $0 | 22,044 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-05-02 | 2023-05-04 | 9,132 | — | $0 | 53,018 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2022-11-22 | 2022-11-23 | 10,000 | $10.50 | $105.0K | 43,886 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2022-05-17 | 2022-05-19 | 6,599 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2022-05-17 | 2022-05-19 | 7,778 | — | $0 | 7,778 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2022-05-17 | 2022-05-19 | 3,168 | $38.57 | $122.2K | 16,886 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2022-05-17 | 2022-05-19 | 6,599 | $38.57 | $254.5K | 20,054 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 28,000 | — | $0 | 28,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2022-04-26 | 2022-04-28 | 9,852 | — | $0 | 53,886 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2021-05-17 | 2021-05-19 | 6,599 | — | $0 | 6,599 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2021-05-07 | 2021-05-11 | 5,804 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2021-05-07 | 2021-05-11 | 2,786 | $42.96 | $119.7K | 13,455 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2021-05-07 | 2021-05-11 | 5,804 | $42.96 | $249.3K | 16,241 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2021-04-27 | 2021-04-29 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2021-04-27 | 2021-04-29 | 9,828 | — | $0 | 44,034 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2020-05-15 | 2020-05-19 | 6,054 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2020-05-15 | 2020-05-19 | 6,054 | $52.76 | $319.4K | 13,343 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2020-05-15 | 2020-05-19 | 2,906 | $52.76 | $153.3K | 10,437 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2020-05-07 | 2020-05-11 | 5,804 | — | $0 | 5,804 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2020-04-28 | 2020-04-30 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2020-04-28 | 2020-04-30 | 6,635 | — | $0 | 34,206 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2019-05-17 | 2019-05-20 | 2,673 | $20.19 | $54.0K | 27,571 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2019-05-16 | 2019-05-20 | 1,327 | $21.00 | $27.9K | 30,244 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2019-05-15 | 2019-05-17 | 6,054 | — | $0 | 6,054 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2019-05-15 | 2019-05-17 | 3,971 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2019-05-15 | 2019-05-17 | 1,907 | $49.55 | $94.5K | 7,289 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2019-05-15 | 2019-05-17 | 3,971 | $49.55 | $196.8K | 9,196 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2019-04-30 | 2019-05-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2019-04-30 | 2019-05-02 | 8,385 | — | $0 | 31,571 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2018-06-06 | 2018-06-08 | 4,265 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2018-06-06 | 2018-06-08 | 4,265 | $73.22 | $312.3K | 7,443 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2018-06-06 | 2018-06-08 | 2,218 | $73.22 | $162.4K | 5,225 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2018-05-15 | 2018-05-17 | 3,971 | — | $0 | 3,971 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2018-05-01 | 2018-05-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2018-05-01 | 2018-05-03 | 8,186 | — | $0 | 23,186 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2017-06-06 | 2017-06-08 | 4,265 | — | $0 | 4,265 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2017-05-31 | 2017-06-02 | 3,263 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2017-05-31 | 2017-06-02 | 1,697 | $72.85 | $123.6K | 3,178 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2017-05-31 | 2017-06-02 | 3,263 | $72.85 | $237.7K | 4,875 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2017-05-17 | 2017-05-18 | 6,000 | — | $0 | 15,000 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-05-19 | 2017-05-19 | 3,263 | — | $0 | 3,263 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-05-19 | 2016-05-23 | 3,263 | — | $0 | 3,263 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2016-05-04 | 2016-05-06 | 924 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2016-05-04 | 2016-05-06 | 924 | $95.70 | $88.4K | 2,093 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2016-05-04 | 2016-05-06 | 481 | $95.70 | $46.0K | 1,612 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2016-05-03 | 2016-05-05 | 6,000 | — | $0 | 9,000 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2015-11-13 | 2015-11-17 | 1,929 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2015-11-13 | 2015-11-17 | 1,929 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2015-11-13 | 2015-11-17 | 926 | $146.90 | $136.0K | 1,247 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2015-11-13 | 2015-11-17 | 1,929 | $146.90 | $283.4K | 2,173 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2015-11-13 | 2015-11-17 | 1,929 | $146.90 | $283.4K | 2,173 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2015-11-13 | 2015-11-17 | 1,004 | $146.90 | $147.5K | 1,169 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2015-11-04 | 2015-11-06 | 924 | $162.29 | $150.0K | 924 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2015-10-21 | 2015-10-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2015-10-21 | 2015-10-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2014-11-13 | 2014-11-17 | 1,929 | — | $0 | 1,929 | SEC↗ |